BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 24989688)

  • 1. Nasal fluid release of eotaxin-3 and eotaxin-2 in persistent sinonasal eosinophilic inflammation.
    De Corso E; Baroni S; Battista M; Romanello M; Penitente R; Di Nardo W; Passali GC; Sergi B; Fetoni AR; Bussu F; Zuppi C; Paludetti G
    Int Forum Allergy Rhinol; 2014 Aug; 4(8):617-24. PubMed ID: 24989688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal lavage CCL24 levels correlate with eosinophils trafficking and symptoms in chronic sino-nasal eosinophilic inflammation.
    De Corso E; Baroni S; Romitelli F; Luca L; Di Nardo W; Passali GC; Paludetti G
    Rhinology; 2011 Jun; 49(2):174-9. PubMed ID: 21743872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitors decrease eotaxin-3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric H,K-ATPase.
    Min JY; Ocampo CJ; Stevens WW; Price CPE; Thompson CF; Homma T; Huang JH; Norton JE; Suh LA; Pothoven KL; Conley DB; Welch KC; Shintani-Smith S; Peters AT; Grammer LC; Harris KE; Hulse KE; Kato A; Modyanov NN; Kern RC; Schleimer RP; Tan BK
    J Allergy Clin Immunol; 2017 Jan; 139(1):130-141.e11. PubMed ID: 27717558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eotaxin-1, -2, and -3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients.
    Yao T; Kojima Y; Koyanagi A; Yokoi H; Saito T; Kawano K; Furukawa M; Kusunoki T; Ikeda K
    Laryngoscope; 2009 Jun; 119(6):1053-9. PubMed ID: 19296494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Fluticasone Furoate Nasal Spray on Parameters of Eosinophilic Inflammation in Patients With Nasal Polyposis and Perennial Allergic Rhinitis.
    Špadijer Mirković C; Perić A; Vukomanović Đurđević B; Vojvodić D
    Ann Otol Rhinol Laryngol; 2017 Aug; 126(8):573-580. PubMed ID: 28587510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial and epithelial expression of eotaxin-2 (CCL24) in nasal polyps.
    Schaefer D; Meyer JE; Pods R; Pethe W; Hedderich J; Schmidt C; Maune S
    Int Arch Allergy Immunol; 2006; 140(3):205-14. PubMed ID: 16682802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal lavage levels of granulocyte-macrophage colony-stimulating factor and chronic nasal hypereosinophilia.
    De Corso E; Baroni S; Lucidi D; Battista M; Romanello M; Autilio C; Morelli R; Di Nardo W; Passali GC; Sergi B; Bussu F; Fetoni AR; Zuppi C; Paludetti G
    Int Forum Allergy Rhinol; 2015 Jun; 5(6):557-62. PubMed ID: 25821067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemokinin-1 stimulates C-C motif chemokine ligand 24 production in macrophages to enhance eosinophilic inflammation in nasal polyps.
    Deng YK; Ma J; Wang ZC; Long XB; Chen CL; Feng QM; Zhang XH; Zeng M; Wang H; Lu X; Liu Z
    Int Forum Allergy Rhinol; 2019 Nov; 9(11):1334-1345. PubMed ID: 31545881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kinetics of allergen-induced eotaxin level in nasal lavage fluid: its key role in eosinophil recruitment in nasal mucosa.
    Terada N; Hamano N; Kim WJ; Hirai K; Nakajima T; Yamada H; Kawasaki H; Yamashita T; Kishi H; Nomura T; Numata T; Yoshie O; Konno A
    Am J Respir Crit Care Med; 2001 Aug; 164(4):575-9. PubMed ID: 11520718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic nasal polyps are a rich source of eotaxin, eotaxin-2 and eotaxin-3.
    Olze H; Förster U; Zuberbier T; Morawietz L; Luger EO
    Rhinology; 2006 Jun; 44(2):145-50. PubMed ID: 16792175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase of high mobility group box chromosomal protein 1 in eosinophilic chronic rhinosinusitis with nasal polyps.
    Chen D; Mao M; Bellussi LM; Passali D; Chen L
    Int Forum Allergy Rhinol; 2014 Jun; 4(6):453-62. PubMed ID: 24504744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and clinical significance of Eotaxin-3 in chronic rhinosinusitis with and without nasal polyps].
    Liu M; Zhao H; Cao Z
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Feb; 30(3):190-3. PubMed ID: 27373085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal interleukin-5, immunoglobulin E, eosinophilic cationic protein, and soluble intercellular adhesion molecule-1 in chronic sinusitis, allergic rhinitis, and nasal polyposis.
    Kramer MF; Ostertag P; Pfrogner E; Rasp G
    Laryngoscope; 2000 Jun; 110(6):1056-62. PubMed ID: 10852530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JESREC score and mucosal eosinophilia can predict endotypes of chronic rhinosinusitis with nasal polyps.
    Nakayama T; Sugimoto N; Okada N; Tsurumoto T; Mitsuyoshi R; Takaishi S; Asaka D; Kojima H; Yoshikawa M; Tanaka Y; Haruna SI
    Auris Nasus Larynx; 2019 Jun; 46(3):374-383. PubMed ID: 30243753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eotaxin-3 as a Plasma Biomarker for Mucosal Eosinophil Infiltration in Chronic Rhinosinusitis.
    Yamada T; Miyabe Y; Ueki S; Fujieda S; Tokunaga T; Sakashita M; Kato Y; Ninomiya T; Kawasaki Y; Suzuki S; Saito H
    Front Immunol; 2019; 10():74. PubMed ID: 30778348
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased expression of the chemokine CCL23 in eosinophilic chronic rhinosinusitis with nasal polyps.
    Poposki JA; Uzzaman A; Nagarkar DR; Chustz RT; Peters AT; Suh LA; Carter R; Norton J; Harris KE; Grammer LC; Tan BK; Chandra RK; Conley DB; Kern RC; Schleimer RP; Kato A
    J Allergy Clin Immunol; 2011 Jul; 128(1):73-81.e4. PubMed ID: 21497884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonselective chemokine levels in nasal secretions of patients with perennial nonallergic and allergic rhinitis.
    Perić A; Sotirović J; Špadijer-Mirković C; Matković-Jožin S; Perić AV; Vojvodić D
    Int Forum Allergy Rhinol; 2016 Apr; 6(4):392-7. PubMed ID: 26679085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia.
    Ho J; Bailey M; Zaunders J; Mrad N; Sacks R; Sewell W; Harvey RJ
    Clin Exp Allergy; 2015 Feb; 45(2):394-403. PubMed ID: 25429730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin (IL)-4 and to a lesser extent either IL-13 or interferon-gamma regulate the production of eotaxin-2/CCL24 in nasal polyps.
    Lezcano-Meza D; Dávila-Dávila B; Vega-Miranda A; Negrete-García MC; Teran LM
    Allergy; 2003 Oct; 58(10):1011-7. PubMed ID: 14510718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidity has no impact on eosinophil inflammation in the upper airways or on severity of the sinonasal disease in patients with nasal polyps.
    Uhliarova B; Kopincova J; Kolomaznik M; Adamkov M; Svec M; Calkovska A
    Clin Otolaryngol; 2015 Oct; 40(5):429-36. PubMed ID: 25688693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.